Patricia L Weng
Overview
Explore the profile of Patricia L Weng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Detection of Subclinical Rejection in Pediatric Kidney Transplantation: Current and Future Practices
Ettenger R, Seifert M, Blydt-Hansen T, Briscoe D, Holman J, Weng P, et al.
Pediatr Transplant
. 2024 Aug;
28(6):e14836.
PMID: 39147695
Introduction: The successes in the field of pediatric kidney transplantation over the past 60 years have been extraordinary. Year over year, there have been significant improvements in short-term graft survival....
2.
Kaplan H, Goldstein S, Rubinson C, Daraiseh N, Zhang F, Rodgers I, et al.
Am J Med Qual
. 2023 Dec;
39(1):21-32.
PMID: 38127682
Context and implementation approaches can impede the spread of patient safety interventions. The objective of this article is to characterize factors associated with improved outcomes among 9 hospitals implementing a...
3.
Marasa M, Ahram D, Rehman A, Mitrotti A, Abhyankar A, Jain N, et al.
Kidney Int Rep
. 2023 Aug;
8(8):1638-1647.
PMID: 37547535
Introduction: The diagnosis and management of proteinuric kidney diseases such as focal segmental glomerulosclerosis (FSGS) are challenging. Genetics holds the promise to improve clinical decision making for these diseases; however,...
4.
Pearl M, Chen L, Zuckerman J, Weng P, Chambers E, Zhang Q, et al.
Transplantation
. 2023 Aug;
108(1):276-283.
PMID: 37527494
Background: Angiotensin II type 1 receptor antibodies (AT1R-Abs) and endothelin-type A receptor antibodies (ETAR-Abs) are G protein-coupled receptor activating autoantibodies associated with antibody-mediated rejection, vascular pathology, increased cytokines, allograft dysfunction,...
5.
Barry A, McNulty M, Jia X, Gupta Y, Debiec H, Luo Y, et al.
Nat Commun
. 2023 Apr;
14(1):2481.
PMID: 37120605
Pediatric steroid-sensitive nephrotic syndrome (pSSNS) is the most common childhood glomerular disease. Previous genome-wide association studies (GWAS) identified a risk locus in the HLA Class II region and three additional...
6.
Ettenger R, Venick R, Gritsch H, Alejos J, Weng P, Srivastava R, et al.
Pediatr Transplant
. 2022 Dec;
27 Suppl 1:e14248.
PMID: 36468338
Background: Since the earliest clinical successes in solid organ transplantation, the proper method of organ allocation for children has been a contentious subject. Over the past 30-35 years, the medical...
7.
Pearl M, Weng P, Chen L, Dokras A, Pizzo H, Garrison J, et al.
Clin Transplant
. 2022 Jun;
36(8):e14734.
PMID: 35657013
Background: Treatment options for antibody-mediated rejection (AMR) are limited. Recent studies have shown that inhibition of interleukin-6 (IL-6)/interleukin-6 receptor (IL-6R) signaling can reduce inflammation and slow AMR progression. Methods: We...
8.
Varnell Jr C, Harshman L, Liu C, Smith L, Al-Akash S, Barletta G, et al.
Pediatr Nephrol
. 2022 May;
38(2):537-547.
PMID: 35538239
Background: We report follow-up data from an ongoing prospective cohort study of COVID-19 in pediatric kidney transplantation through the Improving Renal Outcomes Collaborative (IROC). Methods: Patient-level data from the IROC...
9.
Engen R, Weng P, Shih W, Patel H, Richardson K, Dowdrick S, et al.
Pediatr Transplant
. 2021 Dec;
26(3):e14202.
PMID: 34967072
Background: Neutropenia is common in the first year after pediatric kidney transplant and is associated with an increased risk of infection, allograft loss, and death. Granulocyte colony-stimulating factor (G-CSF) increases...
10.
Farkas-Skiles C, Ettenger R, Zuckerman J, Pearl M, Venick R, Weng P
Pediatr Nephrol
. 2021 Jul;
37(1):153-161.
PMID: 34292379
Background: We propose a novel clinically significant finding, de novo lupus-like glomerulonephritis (DNLLGN), in patients with autoantibodies and kidney abnormalities in pediatric liver transplant (LT) and intestinal inclusive transplants (ITx)....